...
首页> 外文期刊>Archives of Phytopathology and Plant Protection >Prediction of cotton leaf curl virus disease and its management through resistant germplasm and bio-products
【24h】

Prediction of cotton leaf curl virus disease and its management through resistant germplasm and bio-products

机译:通过抗性种质和生物产品预测棉叶卷曲病毒疾病及其管理

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cotton leaf curl virus disease reduces the cotton yield significantly every year and is transmitted by Bemisia tabaci. The study was designed to evaluate 15 varieties/lines against the disease. Multiple regression analysis was performed based on a-biotic environmental variables (maximum air temperature, minimum air temperature, relative humidity and rainfall) to predict disease incidence and its vector (Bemisia tabaci). Two bio-products were evaluated against the whitefly population to control the disease. Out of 15 cotton varieties/ lines, no one was found highly resistant against the disease. Five varieties/lines (BT BT-980, BT-457, KIRAN, BT-666 and SLH-BT-6) exhibited moderately resistant response. Maximum air temperature (34-35.5 °C), minimumtemperature (25.75-26.25 °C), relative humidity (64.14-66%), rainfall (1-2 mm) and wind speed (5.50-5.75 Kmhr1) favoured the disease development. Maximum whitefly population was favoured by maximum air temperature from 34-35.5 °C, 25.8-26.2 °C minimumair temperature, 64.14-66% relative humidity, 1-2 mm from rainfall and 5.50-5.75 Kmh"1 wind speed. Datura stramonium was found more effective as compared to Aviara (Homoeopathic) but not from the positive control (Acetamiprid).
机译:棉叶卷曲病毒疾病每年明显降低棉花产量,并由Bemisia Tabaci传播。该研究旨在评估15个品种/侵害疾病的线。基于A-生物环境变量(最大空气温度,最小空气温度,相对湿度和降雨)来进行多元回归分析,以预测疾病发病率及其载体(Bemisia Tabaci)。评估两种生物产品对粉虱种群进行评估以控制疾病。在15个棉花品种/线条中,没有人对这种疾病的抗性产生高度抗性。五种各种/线(BT BT-980,BT-457,Kiran,BT-666和SLH-BT-6)表现出适度的抗反应。最大空气温度(34-35.5°C),最小温度(25.75-26.25°C),相对湿度(64.14-66%),降雨(1-2毫米)和风速(5.50-5.75 kmhr1)青睐疾病发展。最大的粉虱群体受到34-35.5°C的最大空气温度,25.8-26.2°C的最小气体温度,64.14-66%相对湿度,降雨量为1-2毫米,5.50-5.75 kmh“1风速。Datura Stramonium是与Aviara(同种疗法)相比,但不是从阳性对照(acetamiprid)相比更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号